HRH3 and Cognitive impairment: Among a wide range of H3R antagonists investigated so far, H3R antagonists ABT-239 and A-431404 were found to ameliorate cognitive deficits induced by ketamine and MK-801 in rodents, demonstrating enhanced procognitive effects of these compounds compared to standard drugs, e.g., DOZ (Brown et al., 2013).